VEGF受体结合抑制肽的筛选及其特性鉴定

被引:6
作者
向军俭
黄竞荷
钟振东
杨红宇
向征
机构
[1] 暨南大学生命科学技术学院
[2] 暨南大学生命科学技术学院 广州
[3] 广州
基金
广东省自然科学基金;
关键词
噬菌体随机展示肽库; 血管内皮细胞生长因子; 抗原表位; 合成肽; 疫苗;
D O I
暂无
中图分类号
R346 [];
学科分类号
1001 ;
摘要
目的 筛选能抑制VEGF与血管内皮细胞表面受体结合的VEGF模拟短肽 ,探讨小分子短肽作为血管内皮细胞生长抑制剂、肿瘤疫苗的可行性。方法 以抗 VEGF单克隆抗体分别对噬菌体随机 7肽、12肽库进行筛选。通过硝酸纤维膜斑点印迹法进行阳性克隆鉴定。用噬菌体克隆免疫小鼠检验这种短肽可否模拟VEGF的抗原决定簇诱发机体产生能与VEGF结合的抗体 ,研究小鼠抗血清、噬菌体表达的 7肽和 12肽以及人工合成 7肽对人脐静脉血管内皮细胞 (HUVEC)生长的抑制作用。结果 对肽库进行 3轮筛选后 ,噬菌体克隆具有良好的富集效果。硝酸纤维膜斑点印迹法证实阳性率达到 10 0 % ,测序结果显示噬菌体上的短肽有共同序列 :GWYYDAL、VASAVFYSALVE。这两种噬菌体短肽免疫小鼠能激发产生高效价的抗 VEGF抗体。噬菌体表达的 7肽和 12肽对HUVEC的生长有明显的抑制作用。由短肽GWYYDAL阳性克隆免疫的抗血清对VEGF诱导的内皮细胞生长起抑制作用 ,人工合成的 7肽 (GWYYDAL)呈剂量依赖性阻拮VEGF促HUVEC增殖作用。结论 从噬菌体肽库中筛选到的噬菌体短肽GWYYDAL、VASAVFYSALVE模拟了VEGF的抗原表位 ,为研究VEGF受体结合抑制肽和设计肿瘤疫苗奠定了实验基础。
引用
收藏
页码:46 / 50
页数:5
相关论文
共 14 条
[1]  
VEGF-VEGF receptor complexes as markers of tumor vascular endothelium. Brekken RA,Thorpe PE. Journal of Controlled Release . 2001
[2]  
VEGF in the culture of PMN and the serum in oral cavity cancer patients. Jablonska E,Piotrowski L,Jablonski J. Oral Oncology . 2002
[3]  
Vascular endothelial growth factor(VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R)concentrations in peripheral blood as markers of pituitary tumours. Komorowski J,Jankewica J,Stepien H. Vtobios . 2000
[4]  
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Takahashi Y,Kitadai Y,Bucana C D,et al. Cancer Research . 1995
[5]  
The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1 KDR receptor on vascular endothelial cells. Albini A,Soldi R,Giunciuglio D,et al. Nature Medicine . 1996
[6]  
Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 expression in mdx mouse brain. Beatrice N,Patrizia C,Angelo V. Brain Research . 2002
[7]  
Vascular endothelial growth factor as an agedependent prognostic factor in gastric cancer patients. Eiji M,Chikao M,Kouji K. The American Journal of Surgery . 2002
[8]  
Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survial. Barbara B,Edgar S,Tomas-Hendrik K. Cancer Letters . 2002
[9]  
Vascular endothelial growth factor vascular permeability factor expression in a mouse model of retinal neovascularization. Pierce EA,Avery RL,Foley ED,et al. Proceedings of the National Academy of Sciences of the United States of America . 1995
[10]  
Overexpression of vascular permeability factor vascular endothelial growth factor and its receptors in psoriasis. Detmar M,Brown LF,Claffey KP,et al. The Journal of Experimental Medicine . 1994